Inventor profile of:

Bernhard Fasching

City:

Basel

Country:

Switzerland

Published Applications:

33

Last publication date:

2026-06-04

Top Assignees for applications by Bernhard Fasching

The entities that hold a legal rights for patent applications filed by inventor Fasching Bernhard:

Recent patent applications by Fasching Bernhard

Bernhard Fasching from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04
US20260152482A1
Chemistry; metallurgy

ISOINDOLINONE COMPOUNDS

#2 | 2025-11-06
US20250340528A1
Chemistry; metallurgy

TARGETED PROTEIN DEGRADATION

#3 | 2025-08-21
US20250263395A1
Chemistry; metallurgy

COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF

#4 | 2025-08-14
US20250257048A1
Chemistry; metallurgy

METHODS OF PREPARING AN ISOINDOLINONE DERIVATIVE AND CRYSTAL FORMS THEREOF

#5 | 2025-07-31
US20250243180A1
Chemistry; metallurgy

TARGETED PROTEIN DEGRADATION

#6 | 2025-06-26
US20250205219A1
Human necessities

TARGETED DEGRADATION OF VAV1

#7 | 2025-05-29
US20250171420A1
Chemistry; metallurgy

MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME

#8 | 2025-04-10
US20250115582A1
Chemistry; metallurgy

MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME

#9 | 2025-04-10
US20250115581A1
Chemistry; metallurgy

SUBSTITUTED PIPERIDINES AS CK1A DEGRADERS

#10 | 2025-02-27
US20250066378A1
Chemistry; metallurgy

SPIRO-OXAZOLONES

#11 | 2024-09-26
US20240317706A1
Chemistry; metallurgy

COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF

#12 | 2024-09-19
US20240308976A1
Chemistry; metallurgy

COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF

#13 | 2024-09-12
US20240299559A1
Human necessities

COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF

#14 | 2024-09-05
US20240294495A1
Chemistry; metallurgy

COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF

#15 | 2024-08-29
US20240285604A1
Human necessities

Targeted degradation of VAV1

#16 | 2024-08-22
US20240279218A1
Chemistry; metallurgy

ISOXAZOLYL ETHER DERIVATIVES AS GABA A ALPHA5 PAM

#17 | 2024-07-04
US20240216355A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS

#18 | 2024-03-14
US20240083869A1
Chemistry; metallurgy

ISOINDOLINONE COMPOUNDS

#19 | 2024-02-15
US20240051937A1
Chemistry; metallurgy

ISOINDOLINONE AMIDE COMPOUNDS USEFUL TO TREAT DISEASES ASSOCIATED WITH GSPT1

#20 | 2024-02-15
US20240051936A1
Chemistry; metallurgy

ISOINDOLINONE COMPOUNDS

#21 | 2023-11-02
US20230348418A1
Chemistry; metallurgy

Isoindolinone compounds

#22 | 2023-04-06
US20230106150A1
Chemistry; metallurgy

Spiro-oxazolones

#23 | 2022-12-29
US20220411468A1
Chemistry; metallurgy

Peptide macrocycles against

#24 | 2022-12-29
US20220411415A1
Chemistry; metallurgy

ISOXAZOLYL ETHER DERIVATIVES AS GABA A ALPHA5 PAM

#25 | 2022-08-04
US20220242846A1
Chemistry; metallurgy

ISOINDOLINONE COMPOUNDS

#26 | 2020-02-06
US20200040031A1
Chemistry; metallurgy

Anti-bacterial peptide macrocycles and use thereof

#27 | 2020-02-06
US20200039997A1
Chemistry; metallurgy

Spiro-oxazolones

#28 | 2019-10-03
US20190300516A1
Chemistry; metallurgy

Isoxazolyl ether derivatives as GABAα5 PAM

#29 | 2018-12-20
US20180362578A1
Chemistry; metallurgy

Peptide macrocycles against Acinetobacter baumannii

#30 | 2017-08-31
US20170246153A1
Human necessities

Spiro-thiazolones

#31 | 2017-08-17
US20170233437A1
Chemistry; metallurgy

Peptide macrocycles against acinetobacter baumannii

#32 | 2017-01-12
US20170008901A1
Chemistry; metallurgy

Spiro-oxazolones

#33 | 2016-12-08
US20160355522A1
Chemistry; metallurgy

Spiro-oxazolones

InventorID:

1730545 ⎘